成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart Sign in  
Chemical Structure| 35807-85-3 Chemical Structure| 35807-85-3
Chemical Structure| 35807-85-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

{[proInfo.proName]}

CAS No.: 35807-85-3

,{[proInfo.pro_purity]}

Tauroursodeoxycholate (Tauroursodeoxycholic acid; TUDCA) sodium is an endoplasmic reticulum (ER) stress inhibitor that significantly reduces the expression of apoptosis molecules such as caspase-3 and caspase-12 and also inhibits ERK.

Synonyms: Tauroursodeoxycholic acid sodium; UR 906 sodium; Ursodeoxycholyltaurine sodium

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Alternative Products

Product Details of Tauroursodeoxycholate sodium

CAS No. :35807-85-3
Formula : C26H45NNaO6S
M.W : 522.69
SMILES Code : C[C@@]12[C@]([C@]3([C@@]([C@]4(C)[C@](C[C@@H]3O)(C[C@H](O)CC4)[H])(CC1)[H])[H])(CC[C@@]2([C@@H](CCC(NCCS(=O)(=O)O)=O)C)[H])[H].[Na]
Synonyms :
Tauroursodeoxycholic acid sodium; UR 906 sodium; Ursodeoxycholyltaurine sodium

Safety of Tauroursodeoxycholate sodium

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Tauroursodeoxycholate sodium

MAPK

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03127514 Amyotrophic Lateral Sclerosis ... More >> Motor Neuron Disease Neuromuscular Diseases Neurodegenerative Diseases Spinal Cord Diseases TDP-43 Proteinopathies Nervous System Diseases Central Nervous System Diseases Less << Phase 2 Recruiting May 2019 -
NCT00771901 - Completed - -
NCT03533257 Alzheimer Disease Phase 2 Recruiting September 1, 2020 United States, Illinois ... More >> Rush University Medical Center Recruiting Chicago, Illinois, United States, 60612 Contact: Judy Phillips ?? 312-942-0050 ?? Judy_Phillips@rush.edu ?? United States, Kansas University of Kansas Clinical Research Center Recruiting Fairway, Kansas, United States, 66205 Contact: KUMC Recruitment Division ?? 913-588-0555 ?? KUAMP@kumc.edu ?? United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Alison J McManus, DNP ?? 617-643-4848 ?? ajmcmanus@mgh.harvard.edu ?? Contact: John Ernandez ?? 617-643-4047 ?? jernandez@partners.org ?? United States, New Jersey Rowan University Not yet recruiting Stratford, New Jersey, United States, 08084 Contact: Lauren Fedor ?? 856-566-6003 ?? fedor@rowan.edu ?? United States, New York Mount Sinai Alzheimer's Disease Research Center Not yet recruiting New York, New York, United States, 10029 Contact: Caroline Meuser ?? 212-659-8885 ?? caroline.meuser@mssm.edu ?? Columbia University Recruiting New York, New York, United States, 10032 Contact: Ruth Tejeda ?? 212-305-7661 ?? rbt41@cumc.columbia.edu ?? United States, Pennsylvania Penn Memory Center Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Laura Schankel ?? 215-349-8727 ?? laura.schankel@pennmedicine.upenn.edu Less <<
NCT00771901 Insulin Resistance ... More >> Diabetes Obesity Less << Not Applicable Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.91mL

0.38mL

0.19mL

9.57mL

1.91mL

0.96mL

19.13mL

3.83mL

1.91mL

References

 

Historical Records

Categories